lastID = -288085
Skip to main content Skip to top navigation Skip to site search
Top of page
  • My citations options
    Web Back (from Web)
    Chicago Back (from Chicago)
    MLA Back (from MLA)
Close action menu

You need to login to use this feature.

Please wait a moment…
Please wait while we update your results...
Please wait a moment...
Description: Access Water
Context Menu
Description: Book cover
ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER
  • Browse
  • Compilations
    • Compilations list
  • Subscriptions
Tools

Related contents

Loading related content

Workflow

No linked records yet

X
  • Current: 2022-05-06 12:56:14 Adam Phillips
  • 2022-05-06 12:56:13 Adam Phillips
  • 2020-01-31 19:28:03 Administrator
  • 2020-01-31 19:28:02 Administrator
Description: Access Water
  • Browse
  • Compilations
  • Subscriptions
Log in
0
Accessibility Options

Base text size -

This is a sample piece of body text
Larger
Smaller
  • Shopping basket (0)
  • Accessibility options
  • Return to previous
Description: Book cover
ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER

ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER

ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER

  • New
  • View
  • Details
  • Reader
  • Default
  • Share
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • New
  • View
  • Default view
  • Reader view
  • Data view
  • Details

This page cannot be printed from here

Please use the dedicated print option from the 'view' drop down menu located in the blue ribbon in the top, right section of the publication.

screenshot of print menu option

Description: Book cover
ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER
Abstract
In August 1999, a pharmaceutical manufacturer initiated a wastewater management project for its batch chemical synthesis plant in the southeastern region of the United States (Facility). The goal was to construct a wastewater pretreatment system that would ensure compliance with the Effluent Guidelines, while providing the flexibility to handle variable flows, loads, and regulated solvent compositions. In addition, the new pretreatment system would have to minimize additional hazardous air pollutant (HAP) emissions to allow the Facility to maintain its MACT synthetic minor status.Two treatment schemes were chosen for pilot testing: (1) removal of volatile organic compounds (VOCs) in an air stripper followed by biological treatment in a sequencing batch reactor (SBR) with diffused aeration and, (2) biological treatment in a sequencing batch reactor (SBR) with high purity oxygen (HPO) aeration.Pilot testing was conducted for a period of 10 months using a trailer-mounted SBR pilot unit. Testing of the air stripper plus diffused air SBR was conducted during the first four months. The SBR pilot unit was operated during the following six months as a single-stage HPO SBR system. Influent and effluent samples were collected and analyzed for selected VOCs and conventional wastewater parameters. Comparative testing of the HPO and diffused air systems was conducted using measured spike addition of VOCs to examine the pilot unit's response to changes in influent concentrations. Pilot unit influent, effluent, and off-gas samples were collected during each test for VOC analysis. The test results were used to perform system mass balances.The pilot testing results demonstrated that the both treatment alternatives would comply with the EG criteria. Influent toluene concentrations of 50 to 100 ppm were routinely reduced to below the method detection level of 0.005 ppm. The testing further showed that the HPO biotreatment pilot system provided high VOC removals via biodegradation and very low HAP emissions. Approximately 0.3 percent of the influent toluene load was emitted to the atmosphere with the high purity oxygen system versus 12.6 percent with diffused aeration.
In August 1999, a pharmaceutical manufacturer initiated a wastewater management project for its batch chemical synthesis plant in the southeastern region of the United States (Facility). The goal was to construct a wastewater pretreatment system that would ensure compliance with the Effluent Guidelines, while providing the flexibility to handle variable flows, loads, and regulated solvent...
Author(s)
Allison G. RodieckCarl GeilingErika L. BaileyCharles J. ReithJoel Cohn
SourceProceedings of the Water Environment Federation
SubjectSession 22 - Industrial Issues and Treatment Technology Symposium: Pharmaceutical and Chemical Industries
Document typeConference Paper
PublisherWater Environment Federation
Print publication date Jan, 2001
ISSN1938-6478
SICI1938-6478(20010101)2001:14L.163;1-
DOI10.2175/193864701802779648
Volume / Issue2001 / 14
Content sourceWEFTEC
First / last page(s)163 - 191
Copyright2001
Word count337

Purchase price $11.50

Get access
Log in Purchase content Purchase subscription
You may already have access to this content if you have previously purchased this content or have a subscription.
Need to create an account?

You can purchase access to this content but you might want to consider a subscription for a wide variety of items at a substantial discount!

Purchase access to 'ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER'

Add to cart
Purchase a subscription to gain access to 18,000+ Proceeding Papers, 25+ Fact Sheets, 20+ Technical Reports, 50+ magazine articles and select Technical Publications' chapters.
Loading items
There are no items to display at the moment.
Something went wrong trying to load these items.
Description: Book cover
ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER
Pricing
Non-member price: $11.50
Member price:
-288085
Get access
-288085
Log in Purchase content Purchase subscription
You may already have access to this content if you have previously purchased this content or have a subscription.
Need to create an account?

You can purchase access to this content but you might want to consider a subscription for a wide variety of items at a substantial discount!

Purchase access to 'ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER'

Add to cart
Purchase a subscription to gain access to 18,000+ Proceeding Papers, 25+ Fact Sheets, 20+ Technical Reports, 50+ magazine articles and select Technical Publications' chapters.

Details

Description: Book cover
ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER
Abstract
In August 1999, a pharmaceutical manufacturer initiated a wastewater management project for its batch chemical synthesis plant in the southeastern region of the United States (Facility). The goal was to construct a wastewater pretreatment system that would ensure compliance with the Effluent Guidelines, while providing the flexibility to handle variable flows, loads, and regulated solvent compositions. In addition, the new pretreatment system would have to minimize additional hazardous air pollutant (HAP) emissions to allow the Facility to maintain its MACT synthetic minor status.Two treatment schemes were chosen for pilot testing: (1) removal of volatile organic compounds (VOCs) in an air stripper followed by biological treatment in a sequencing batch reactor (SBR) with diffused aeration and, (2) biological treatment in a sequencing batch reactor (SBR) with high purity oxygen (HPO) aeration.Pilot testing was conducted for a period of 10 months using a trailer-mounted SBR pilot unit. Testing of the air stripper plus diffused air SBR was conducted during the first four months. The SBR pilot unit was operated during the following six months as a single-stage HPO SBR system. Influent and effluent samples were collected and analyzed for selected VOCs and conventional wastewater parameters. Comparative testing of the HPO and diffused air systems was conducted using measured spike addition of VOCs to examine the pilot unit's response to changes in influent concentrations. Pilot unit influent, effluent, and off-gas samples were collected during each test for VOC analysis. The test results were used to perform system mass balances.The pilot testing results demonstrated that the both treatment alternatives would comply with the EG criteria. Influent toluene concentrations of 50 to 100 ppm were routinely reduced to below the method detection level of 0.005 ppm. The testing further showed that the HPO biotreatment pilot system provided high VOC removals via biodegradation and very low HAP emissions. Approximately 0.3 percent of the influent toluene load was emitted to the atmosphere with the high purity oxygen system versus 12.6 percent with diffused aeration.
In August 1999, a pharmaceutical manufacturer initiated a wastewater management project for its batch chemical synthesis plant in the southeastern region of the United States (Facility). The goal was to construct a wastewater pretreatment system that would ensure compliance with the Effluent Guidelines, while providing the flexibility to handle variable flows, loads, and regulated solvent...
Author(s)
Allison G. RodieckCarl GeilingErika L. BaileyCharles J. ReithJoel Cohn
SourceProceedings of the Water Environment Federation
SubjectSession 22 - Industrial Issues and Treatment Technology Symposium: Pharmaceutical and Chemical Industries
Document typeConference Paper
PublisherWater Environment Federation
Print publication date Jan, 2001
ISSN1938-6478
SICI1938-6478(20010101)2001:14L.163;1-
DOI10.2175/193864701802779648
Volume / Issue2001 / 14
Content sourceWEFTEC
First / last page(s)163 - 191
Copyright2001
Word count337

Actions, changes & tasks

Outstanding Actions

Add action for paragraph

Current Changes

Add signficant change

Current Tasks

Add risk task

Connect with us

Follow us on Facebook
Follow us on Twitter
Connect to us on LinkedIn
Subscribe on YouTube
Powered by Librios Ltd
Powered by Librios Ltd
Authors
Terms of Use
Policies
Help
Accessibility
Contact us
Copyright © 2024 by the Water Environment Federation
Loading items
There are no items to display at the moment.
Something went wrong trying to load these items.
Description: WWTF Digital Boot 180x150
WWTF Digital (180x150)
Created on Jul 02
Websitehttps:/­/­www.wef.org/­wwtf?utm_medium=WWTF&utm_source=AccessWater&utm_campaign=WWTF
180x150
Allison G. Rodieck# Carl Geiling# Erika L. Bailey# Charles J. Reith# Joel Cohn. ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER. Alexandria, VA 22314-1994, USA: Water Environment Federation, 2018. Web. 29 Sep. 2025. <https://www.accesswater.org?id=-288085CITANCHOR>.
Allison G. Rodieck# Carl Geiling# Erika L. Bailey# Charles J. Reith# Joel Cohn. ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER. Alexandria, VA 22314-1994, USA: Water Environment Federation, 2018. Accessed September 29, 2025. https://www.accesswater.org/?id=-288085CITANCHOR.
Allison G. Rodieck# Carl Geiling# Erika L. Bailey# Charles J. Reith# Joel Cohn
ALTERNATIVE TREATMENT STRATEGY FOR A HIGH STRENGTH PHARMACEUTICAL WASTEWATER
Access Water
Water Environment Federation
December 22, 2018
September 29, 2025
https://www.accesswater.org/?id=-288085CITANCHOR